BioMall
Brand Store/BDB Bioscience/BD HorizonTM BV650 Hamster Anti-Mouse CD279 (PD-1)
BD HorizonTM BV650 Hamster Anti-Mouse CD279 (PD-1)
GENERAL CATALOGUE

BD HorizonTM BV650 Hamster Anti-Mouse CD279 (PD-1)

569506 ·

BDB Bioscience · Cat: 569506

₹300 – ₹450 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 569506
Category: reagents
Brand: BDB Bioscience

Description

Flow cytometric analysis of CD279 PD-1 expression on nonactivated and activated Mouse splenocytes. C57BL/6 Mouse splenic leucocytes were either not activated Left Plot or activated Right Plot in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 553057 for 3 days. The cells were harvested and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were then stained with either BD Horizon BV650 Hamster IgG2, kappa Isotype Control Cat. No. 563860; dashed line histograms or BD Horizon BV650 Hamster Anti-Mouse CD279 PD-1 antibody Cat. No. 569506; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing CD279 PD-1 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of CD279 PD-1 expression on nonactivated and activated Mouse splenocytes. C57BL/6 Mouse splenic leucocytes were either not activated Left Plot or activated Right Plot in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 553057 for 3 days. The cells were harvested and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were then stained with either BD Horizon BV650 Hamster IgG2, kappa Isotype Control Cat. No. 563860; dashed line histograms or BD Horizon BV650 Hamster Anti-Mouse CD279 PD-1 antibody Cat. No. 569506; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing CD279 PD-1 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of CD279 PD-1 expression on nonactivated and activated Mouse splenocytes. C57BL/6 Mouse splenic leucocytes were either not activated Left Plot or activated Right Plot in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 553057 for 3 days. The cells were harvested and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were then stained with either BD Horizon BV650 Hamster IgG2, kappa Isotype Control Cat. No. 563860; dashed line histograms or BD Horizon BV650 Hamster Anti-Mouse CD279 PD-1 antibody Cat. No. 569506; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing CD279 PD-1 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of CD279 PD-1 expression on nonactivated and activated Mouse splenocytes. C57BL/6 Mouse splenic leucocytes were either not activated Left Plot or activated Right Plot in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 553057 for 3 days. The cells were harvested and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were then stained with either BD Horizon BV650 Hamster IgG2, kappa Isotype Control Cat. No. 563860; dashed line histograms or BD Horizon BV650 Hamster Anti-Mouse CD279 PD-1 antibody Cat. No. 569506; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing CD279 PD-1 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of CD279 PD-1 expression on nonactivated and activated Mouse splenocytes. C57BL/6 Mouse splenic leucocytes were either not activated Left Plot or activated Right Plot in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 553057 for 3 days. The cells were harvested and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were then stained with either BD Horizon BV650 Hamster IgG2, kappa Isotype Control Cat. No. 563860; dashed line histograms or BD Horizon BV650 Hamster Anti-Mouse CD279 PD-1 antibody Cat. No. 569506; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing CD279 PD-1 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of CD279 PD-1 expression on nonactivated and activated Mouse splenocytes. C57BL/6 Mouse splenic leucocytes were either not activated Left Plot or activated Right Plot in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody Cat. No. 553057 for 3 days. The cells were harvested and preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553141/553142 . The cells were then stained with either BD Horizon BV650 Hamster IgG2, kappa Isotype Control Cat. No. 563860; dashed line histograms or BD Horizon BV650 Hamster Anti-Mouse CD279 PD-1 antibody Cat. No. 569506; solid line histograms at 0.5 mug/test. DAPI 4,6-Diamidino-2-Phenylindole, Dihydrochloride Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histogram showing CD279 PD-1 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leucocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific.

More from BDB Bioscience

BD HorizonTM BV421 Mouse Anti-Human TIGIT
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents